Skip to main content

Where Are They Now?: Jul 1, 2003

Premium

In last July’s issue of Genome Technology, our cover story gave you an in-depth look at genomics research at NIH, starting with an interview with NHGRI’s Francis Collins. He spoke in particular about his institute’s dedication to technology development, spending about $25 million each year on it. That money could be paying off for the genomics community. NHGRI helps fund many grants for new sequencing technologies — and, as you’ll see on page 40 of this issue, some of those technologies could be ready to go in a few years or less.

The July 2002 issue also looked at Gene Codes, which was working overtime using its bioinformatics expertise to identify the remains of victims of the World Trade Center disaster. Just three months later, we announced that Howard Cash, head of the company, was chosen by our readers as the Genome Technology All-Star Person of the Year for that work.

 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.